Research on CBD for Alzheimer’s Disease

(2017) In vivo Evidence for Therapeutic Properties of Cannabidiol (CBD) for Alzheimer’s Disease.

(2015) Cannabis-based medicine reduces multiple pathological processes in AβPP/PS1 mice.

(2015) Cannabinoids in Late-Onset Alzheimer’s Disease.

(2014) The role of endocannabinoid signaling in the molecular mechanisms of neurodegeneration in Alzheimer’s disease.

(2014) Natural Cannabinoids Improve Dopamine Neurotransmission and Tau and Amyloid Pathology in a Mouse Model of Tauopathy.

(2014) Chronic cannabidiol treatment improves social and object recognition in double transgenic APPswe/PS1∆E9 mice.

(2014) Cannabinoid effects on β amyloid fibril and aggregate formation, neuronal and microglial-activated neurotoxicity in vitro.

(2012) The endocannabinoid system in normal and pathological brain ageing.

(2011) Cannabidiol reduces Aβ-induced neuroinflammation and promotes hippocampal neurogenesis through PPARγ involvement.

(2011) Cannabidiol protects against hepatic ischemia/reperfusion injury by attenuating inflammatory signaling and response, oxidative/nitrative stress, and cell death.

(2007) Cannabidiol in vivo blunts beta-amyloid induced neuroinflammation by suppressing IL-1beta and iNOS expression.

(2006) Cannabidiol inhibits inducible nitric oxide synthase protein expression and nitric oxide production in beta-amyloid stimulated PC12 neurons through p38 MAP kinase and NF-kappaB involvement. 

(2006) A novel cannabinoid peripheral cannabinoid receptor-selective inverse agonist blocks leukocyte recruitment in vivo

(2005) Comparison of Cannabidiol, Antioxidants, and Diuretics in Reversing Binge Ethanol-Induced Neurotoxicity.

(2004) Differential effects of THC- or CBD-rich cannabis extracts on working memory in rats. 

(2003) Nonpsychotropic cannabinoid receptors regulate microglial cell migration.

(2002) Neuroprotective properties of cannabinoids against oxidative stress: Role of the cannabinoid receptor CB1.

(2001) Genes, models and Alzheimer’s disease.

(1992) Glutamate and other CSF amino acids in Alzheimer’s disease.